InTest Q2 2026 preliminary earnings: Revenue guidance rises as margin target falls

InTest Corporation (NYSE American: INTT) estimated Q2 2026 revenue at approximately $35 million for the quarter ended June 30, above its prior $32 million to $34 million guidance range, while gross margin was approximately 40%. Strengthening demand supported revenue, but unfavorable Alfamation project mix and a supply-chain disruption reduced the margin by about 500 basis points versus guidance. The figures are preliminary, with finalized results scheduled for August 10, 2026.

Core Earnings Data

The preliminary update compared Q2 estimates with management’s prior guidance rather than with prior-year results. Revenue was about $1 million above the top of the earlier range, operating expenses remained within guidance, and gross margin was materially lower than expected.

These estimates remain subject to the completion of InTest’s financial closing procedures.

Stronger demand lifted revenue, but mix and shipment timing cut margin

InTest attributed the better-than-guided revenue to strengthening demand across several end markets. The improvement in demand did not translate into the expected gross margin because of two operational factors.

Lower-than-expected margins on Alfamation projects accounted for approximately 340 basis points of the total Q2 margin shortfall. Management identified unfavorable project mix as the cause.

A supply-chain disruption also delayed approximately $2 million of ITS revenue into the third quarter. The resulting volume pressure in the Environmental Technologies segment accounted for the remaining approximately 160 basis points of the shortfall. Because the revenue was delayed rather than described as canceled, its conversion in Q3 will be an important operating indicator.

Profitability and internal controls

The Q2 margin pressure follows a separate accounting issue at Alfamation. Implementation problems involving a new ERP system contributed to overstated inventory and gross margin in the first quarter of 2026. Following a June 30 physical inventory count and a review of project costs, InTest determined that Q1 consolidated gross profit was overstated by approximately $750,000.

The company plans to revise Q1 gross margin downward by 220 basis points and record an approximately $750,000 reduction in inventory with a corresponding increase in cost of sales. InTest determined that the identified error was not material to Q1 and said amendments to previously filed reports were not required. However, because it could not conclude that the error could not have been larger, the company expects to report a material weakness in internal control over financial reporting.

Management believes the weakness has been remediated, but InTest still needs to demonstrate that the revised controls operate effectively through fiscal year-end.

Full-Year Guidance

InTest raised its 2026 revenue outlook based on year-to-date performance, stronger customer demand and anticipated second-half order activity. At the same time, it lowered the gross-margin target to reflect weaker Alfamation margins in the first two quarters, partially offset by an expected shift toward higher-margin revenue in the second half.

The company reported a year-to-date gross margin of approximately 41.8%. Reaching the full-year target of about 43% therefore depends on the anticipated improvement in second-half revenue mix and better execution at Alfamation.

Management’s View

CFO Duncan Gilmour acknowledged that the Alfamation gross-margin overstatement should have been identified sooner. He also said InTest is reducing its estimated margins on Alfamation orders scheduled for delivery during the second half.

CEO Rich Rogoff described operational discipline and alignment between the company’s systems, processes and growth as a top priority. He cited stronger demand across the sales funnel as the basis for the higher revenue outlook while maintaining a focus on operating leverage and adjusted EBITDA expansion.

Risks Investors Need to Watch

• Preliminary results may change: The Q2 figures remain subject to completion of the company’s closing procedures, so finalized revenue, margin and expenses may differ.
• Alfamation margin execution: Unfavorable project mix affected Q2, and management has already lowered estimated margins for Alfamation orders expected in the second half.
• Internal-control effectiveness: InTest expects to report a material weakness related to the ERP and inventory issue. The company must still demonstrate that its remediation works effectively through year-end.
• Supply-chain and shipment timing: A disruption moved approximately $2 million of ITS revenue into Q3. Additional delays could affect segment volume and the timing of revenue recognition.
• Dependence on second-half mix: The full-year gross-margin target assumes a higher-margin revenue mix than in the first half, making the composition—not only the amount—of second-half revenue important.

Summary

InTest’s preliminary Q2 results show improving demand and revenue above prior guidance, but profitability was constrained by Alfamation project mix and a delayed ITS shipment. The higher full-year revenue range indicates greater expected sales activity, while the lower margin target and Q1 accounting revision place more weight on second-half execution, internal-control remediation and the conversion of delayed orders into revenue.